These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3179444)

  • 1. Development of the human coagulation system in the healthy premature infant.
    Andrew M; Paes B; Milner R; Johnston M; Mitchell L; Tollefsen DM; Castle V; Powers P
    Blood; 1988 Nov; 72(5):1651-7. PubMed ID: 3179444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the human coagulation system in the full-term infant.
    Andrew M; Paes B; Milner R; Johnston M; Mitchell L; Tollefsen DM; Powers P
    Blood; 1987 Jul; 70(1):165-72. PubMed ID: 3593964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation indices in very preterm infants from cord blood and postnatal samples.
    Neary E; McCallion N; Kevane B; Cotter M; Egan K; Regan I; Kirkham C; Mooney C; Coulter-Smith S; Ní Áinle F
    J Thromb Haemost; 2015 Nov; 13(11):2021-30. PubMed ID: 26334448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation studies in extremely premature infants.
    Barnard DR; Simmons MA; Hathaway WE
    Pediatr Res; 1979 Dec; 13(12):1330-5. PubMed ID: 523193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of the hemostatic system during childhood.
    Andrew M; Vegh P; Johnston M; Bowker J; Ofosu F; Mitchell L
    Blood; 1992 Oct; 80(8):1998-2005. PubMed ID: 1391957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris.
    Vaziri ND; Kennedy SC; Kennedy D; Gonzales E
    Am J Med; 1992 Dec; 93(6):651-7. PubMed ID: 1466361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal haemostatic parameters in correlation to gestational age and birth weight.
    Mitsiakos G; Katsaras GN; Pouliakis A; Papadakis E; Chatziioannidis I; Mitsiakou C; Gialamprinou D; Papacharalampous E; Kioumi A; Athanasiou M; Athanassiadou F; Sfoungaris D; Nikolaidis N
    Int J Lab Hematol; 2022 Oct; 44(5):952-958. PubMed ID: 35815444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and cord blood hemostasis at delivery.
    Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
    J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of blood coagulation activators and inhibitors in the healthy human fetus.
    Reverdiau-Moalic P; Delahousse B; Body G; Bardos P; Leroy J; Gruel Y
    Blood; 1996 Aug; 88(3):900-6. PubMed ID: 8704247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND; Gonzales EC; Wang J; Said S
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months.
    Salonvaara M; Riikonen P; Vahtera E; Mahlamäki E; Heinonen K; Kekomäki R
    Thromb Haemost; 2004 Oct; 92(4):688-96. PubMed ID: 15467897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants.
    Salonvaara M; Riikonen P; Kekomäki R; Vahtera E; Mahlamäki E; Halonen P; Heinonen K
    Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F319-23. PubMed ID: 12819166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood clotting disorders during experimental sarcocystiosis in calves.
    Daugschies A; Rupp U; Rommel M
    Int J Parasitol; 1998 Aug; 28(8):1187-94. PubMed ID: 9762563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system.
    Julius U; Siegert G; Gromeier S
    Int J Artif Organs; 2000 Mar; 23(3):199-206. PubMed ID: 10795665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factors in the premature infant born after about 32 weeks of gestation.
    Terwiel JP; Veltkamp JJ; Bertina RM; van der Linden IK; van Tilburg NH
    Biol Neonate; 1985; 47(1):9-18. PubMed ID: 3967058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status.
    Andrew M; Massicotte-Nolan PM; Karpatkin M
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):495-500. PubMed ID: 6193532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.